Clinical Trial Update: A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating MK2578 for anemia in chronic kidney disease was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MK2578 (MK2578)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2012-03-29